Amin Ramezani

11PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical devicesIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 18, 2026
Integrative analysis identifies candidate biomarkers for bladder cancer: evidence from genomic and clinical validation.

|Oct 28, 2024
Anti-PD-L1 chimeric antigen receptor natural killer cell: Characterization and functional analysis.

Mahsa Yazdanpanah-Samani, Amin Ramezani, Abdolkarim Sheikhi

|Sep 16, 2024
Activation of T Lymphocytes with Anti-PDL1-BiTE in the Presence of Adipose-Derived Mesenchymal Stem Cells (ASCs).

Leila Moeinzadeh, Amin Ramezani, Fereshteh Mehdipour

|Jun 12, 2024
Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6.

Mohammadrasul Zareinejad, Zahra Faghih, Amin Ramezani

|Dec 16, 2023
Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies.

Maryam Asadi, Razie Kiani, Vahid Razban

|Jun 28, 2023
Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells.

Amin Ramezani, Mohammadrasul Zareinejad, Elham Mahmoudi Maymand

Pageof 2

Frequent Collaborators

2 joint publications

Mahsa Yazdanpanah-Samani

2 joint publications

Nasrollah Erfani

2 joint publications

Elham Mahmoudi Maymand

2 joint publications

Abbas Ghaderi